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Abstract
Background: Older adults with multiple chronic illnesses are at risk for worsening functional and medical status
and hospitalization. Home telemonitoring may help slow this decline. This protocol of a randomized controlled trial
was designed to help determine the impact of home telemonitoring on hospitalization. The specific aim of the
study reads as follows: to determine the effectiveness of home telemonitoring compared with usual care in
reducing the combined outcomes of hospitalization and emergency department visits in an at-risk population
60 years of age or older.
Methods/Design: Two-hundred patients with the highest 10% Mayo Clinic Elder Risk Assessment scores will be
randomly assigned to one of two interventions. Home telemonitoring involves the use of a computer device, the
Intel Health Guide, which records biometric and symptom data from patients in their homes. This information is
monitored by midlevel providers associated with a primary care medical practice. Under the usual care scenario,
patients make appointments with their providers as problems arise and use ongoing support such as a 24-hour
nurse line.
Patients will have initial evaluations of gait and quality of life using instruments such as the SF-12 Health Survey, the
Kokmen Short Test of Mental Status, and the PHQ-9 health questionnaire. Patients will be followed for 1 year for pri-
mary outcomes of hospitalizations and emergency department visits. Secondary analysis will include quality of life, com-
pliance with the device, and attitudes about telemonitoring. Sample size is based on an 80% power to detect a 36%
difference between the two groups. The primary analysis will involve Cox proportional time-to-event analysis. Second-
ary analysis will use t-test comparisons for continuous variables and the chi square test for proportional analysis.
Discussion: Patients randomized to home telemonitoring will have daily assessments of their health status using
the device. Registered nurse monitoring will assess any change in status followed by videoconferencing by a mid-
level provider. We obtained trial registration and Institutional Review Board approval.
Trial registration: Trial registration number through http://www.clinicaltrials.gov: NCT01056640.
Background
Older adults with multiple chronic conditions endure
functional decline and loses independence. An estimated
two thirds of deaths in the older population are due to
chronic diseases. Five percent of patients are responsible
for 50% of the costs in most healthcare systems [1]. Yet
the healthcare system often places the burden of acces-
sing healthcare on the individual patient. While this task
may be easy for healthy younger adults, the older, frail
population encounters numerous obstacles, including
difficulty recognizing important changes in status. In
response, healthcare systems have attempted to preemp-
tively evaluate at-risk patients prior to functional
decline. These methods have included more frequent
prescheduled outpatient physician visits, home phone
calls from the physician office, home healthcare, and
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each of these methods has its advantages, they are
labor- and time-intensive processes that may exacerbate
the healthcare worker shortage
2. They also may miss the
mark in caring for at-risk patients. Clearly, we need a
more timely system of providing optimal care to chroni-
cally ill patients. Home telemonitoring, the use of audio,
video, and other telecommunication technologies to
monitor patient status at a distance, has emerged as a
viable method for caring for this population.
Home telemonitoring may reduce hospital admissions,
emergency department (ED) visits, and hospital length
of stay [2]. A systematic review suggests a 20% reduc-
tion in hospitalization in home telemonitoring groups
compared with the usual care in patients with cardiovas-
cular disease [3]. However, it remains unclear if home
telemonitoring will reduce hospitalizations and ED visits
in older patients with multiple medical problems. We
propose to answer this question in a sample of high-risk
adults at least 60 years of age with mixed chronic dis-
eases in a randomized controlled trial. Our primary aim
is to evaluate the effectiveness of home telemonitoring
for reducing hospitalizations, emergency department vis-
its, and the composite outcomes of hospitalizations and
ED visits compared with usual care. Our secondary aims
are to evaluate the effectiveness of home telemonitoring
for improving functional status, quality of life, patient
attitudes, behaviors, compliance, mood, and cognitive
status compared with usual care. Furthermore, we
intend to evaluate the effectiveness of home telemoni-
toring for decreasing total healthcare costs, 30-day re-
hospitalization rates, and hospital bed days.
Methods/Design
Study design
This multi-site, randomized controlled trial of home tele-
monitoring or usual care will take place in the four sites
of the outpatient practice of Mayo Clinic’s Division of
Primary Care Internal Medicine (PCIM) in the Depart-
ment of Family Medicine (FM) in Rochester, Minn. and
nearby Kasson, Minn. The Mayo Elder Risk Assessment
(ERA) Index will be used to randomly assign 200 high-
risk patients to home telemonitoring or usual care (100
patients per intervention). Patients will be followed for 1
year after enrollment. Patients in the Rochester practice
will be block-randomized as a single entity, and the
patients in the Kasson practice will be block-randomized
as a second entity. Subjects and providers will not be
blinded to the allocation of the intervention, but analysis
will be blinded to the allocation type.
Human Subjects approval and Informed Consent
We obtained institutional review board approval from
the Mayo Clinic Institutional Review Board (IRB) on
Oct. 30, 2009. All patients provided written informed
consent prior to enrollment and randomization. All
written communication and the informed consent and
protocol were reviewed by the IRB.
Patient populations
The identification of high-risk older adults in the PCIM
practice has centered on the development of the ERA,
which uses the Mayo Clinic administrative databases
and the Generic Disease Management System (GDMS)
to electronically identify high-risk older adults who live
in an assisted-living setting. Each patient older than 60
years in the PCIM and FM panel receives a score and
quartile placement. The specific scoring for the ERA is
detailed in Table 1. Patients with an ERA score greater
than 16 will be included in the study.
Exclusion criteria
Patients who live in a nursing home, have a clinical
diagnosis of dementia, have a score of 29 or higher on
the Kokmen Short Test of Mental Status, cannot give
informed consent, or do not have the ability to use the
Intel Health Guide (due to severe visual impairment and
lack of a caregiver, an unwillingness to use the device,
or lack of a grounded outlet or 3G mobile communica-
tions coverage) are excluded from the study.
Demographic and practice information
Most residents of Olmsted County who are age 60 or
older are female and white (>90%) [4]. While county
residents are largely Northern European, the ERA index
places this ethnicity as a high-risk population; thus, the
potential sample may slightly over represent under-
served minorities as a high-risk group.
Table 1 Scoring system of the Mayo Clinic Elder Risk
Assessment
Married -1
Age 70-79 1
Age 80-89 3
Age 90 or older 7
Race - Black 6
Race - Other 0
Race - Unknown -6
1-5 hospital days in previous 2 years; 5
6 or more hospital days in previous 2 years 11
History of diabetes 2
History of CAD/MI/CHF 3
History of stroke 2
History of COPD 5
CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary disease; MI, myocardial infarction.
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about 21, 000 patients in this age group. The selection
criteria of a score of 16 or greater on the ERA places
these individuals in the upper decile of risk for hospitali-
zations, ED visits, nursing home placement, and death.
The ERA is an electronically derived index number pro-
vided to all patients in the in PCIM and FM via the
GDMS (Table 1).
Intervention - home telemonitoring
The Intel Health Guide is a U.S. Food and Drug Admin-
istration-approved device that is placed in the patient’s
home and connected to the health system via broadband
Internet or 3G network. This device has video monitor-
ing that allows real-time, face-to-face interaction with
the provider team. Peripheral devices can be attached to
measure blood pressure and pulse, oxygen saturation via
pulse oximetry, glucose level via glucometer, and weight.
The device incorporates a programmable, patient condi-
tion-specific touch-screen questionnaire for daily pro-
gress reporting.
The initial data collected is downloaded to the Web-
based Intel Health Suite for access by the provider
group via the Internet from any PC-based computer.
Each patient has an individualized protocol of daily
assessment questions and biometric parameters with
predetermined action thresholds that are developed,
revised, and monitored by the care team. An overview
of the health guidelines is provided in Table 2. An
example of one such parameter is the daily measure-
ment of weight for patients with heart failure. If the
weight falls outside of preset minimum or maximum
values, the Intel Health Suite highlights the abnormality
for the monitoring provider group.
The implementation and monitoring of the Intel
Health Guide involves a team of individuals. GE Health-
care installs the system, and a clinical assistant educates
the patient on how to use the Intel Health Guide and
serves as a contact for questions on the device or per-
ipherals. The protocols are determined and loaded into
the device by a registered nurse (RN) and modified by a
nurse practitioner (NP) overseeing the care. The
patient’s primary care physician oversees the overall
medical care of the telemonitoring through input from
the RN or NP. One RN oversees the 100 subjects on the
study every day.
The system provides alerts and feedback if there is a
worrisome response to a question or if vital signs are
outside of preset limits. The RN communicates with the
patient and seeks assistance from the subject’s primary
care provider or the overseeing NP for management
issues. The NP or RN communicates with the patient
via teleconferencing to facilitate appropriate actions,
which may include limited advice, reset thresholds,
timely provider outpatient visit, or ED evaluation. The
use of qualified staff allows for diagnostic and treatment
decisions for a wide variety of complex medical condi-
tions that may not be amenable to protocol-based care.
The participants are told to call 911 for emergencies
because the Intel Health Guide is not a life-saving
device.
Intervention - usual care
The usual care intervention includes appropriate pri-
mary care and specialty office practice visits, as required.
It also includes home healthcare, post-hospital outpati-
ent visits, a nurse-generated phone call progress report
within 1 business day of hospital dismissal, and standard
clinic phone triage during business hours. It also
i n v o l v e sa2 4 - h o u rn u r s et r i a g el i n ef o rq u e s t i o n s .
Patients are informed of the currently available options
to patients, including the previously mentioned options,
extended-hours care, and Mayo Clinic Express Care.
Data collection
Data will be collected by the research team and main-
tained electronically in the Mayo system, which is
backed up daily. All paper questionnaires will be col-
lected and entered into the electronic environment for
analysis via data entry using a double-entry method. To
ensure standardized processing, all investigators and
study team members will be formally educated on the
questionnaire and the examination instruments.
Data handling and security
All patient information from the Intel Health Guide will
be sent to a central repository in Arizona. This informa-
tion will be available to the telemonitoring clinical team.
The Intel Health Guide is a secure system that complies
with Health Insurance Portability and Accountability
Act (HIPAA) patient safety regulations. It has a highly
encrypted format in a remote database, and transmis-
sions are secured via the communication protocol
Secure Sockets Layer.
Assessments
All patients enrolled in the study will participate in
three face-to-face visits and two phone calls. The initial
visit, 6-month visit, and 12-month visit will use instru-
ments to measure functional status, quality of life, cog-
nition, mood, self-reported outcomes, attitudes,
Table 2 Intel Health Guide health guidelines (general)
Measurement Normal range
Systolic blood pressure <140 mm Hg
Diastolic blood pressure <90 mm Hg
Pulse oximetry >88%
Weight gain of 2 pounds/day <2 pounds a day
Weight gain of 5 pounds/week <5 pounds gain a week
Fasting blood sugar 80-120 mg/dL
Heart rate 60-100 beats/min.
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patient’s Mayo current visit information and family his-
tory will be collected. At 3 months and 9 months, the
study team will call the patient for descriptions of qual-
i t yo fl i f ea n dm o o d .I ft h er e s u l t si n d i c a t ear i s kt ot h e
patient, the patient’s primary care physician will be con-
tacted. Specifically, if the patient health questionnaire
PHQ-9 indicates depression (score >14) [5], or the Kok-
men Short Test of Mental Status indicates memory loss
or changes of functional status (≤29) [6], this finding
will be reported to the primary care physician.
The instruments used in this study measure quality of
life, mood, functional status, activities of daily living,
caregiver burden, and self-reported outcomes of hospita-
lization and ED visits. The SF-12, the short form of the
SF-36, which measures quality of life and psychosocial
factors [7], will determine if the quality of life has chan-
ged due to the intervention. The PHQ-9 is a validated
instrument that measures depression using Diagnostic
and Statistical Manual (DSM) 4 criteria for depression
[5] and a scoring mechanism that can measure depres-
sive symptoms over time. The Kokmen Short Test of
Mental Status screens for cognitive decline using a 38-
point screening instrument [6]. The functional measures
include grip strength with tonometry, which can directly
measure a person’s strength in the upper extremities [8].
Both upper extremities will be tested and the best result
used as the primary measure. The timed up-and-go test
is a validated instrument that measures the ability to
rise from a chair, turn, and return to the chair [9].
Lastly, gait speed is measured in meters per second. The
patient is told to walk as quickly as possible for 6 meters.
Standards for gait speed are established for older adults
[10]. The Barthel Index is a self-reported questionnaire
that evaluates activities of daily living for the subject
[11]. The Caregiver Quality of Life Scale is used as the
standard instrument for measuring caregiver stress and
feelings. Outcomes include hospital admissions and vis-
its to the ED within the past 3 months. The healthcare
providers are surveyed once in the pre-stages of the
study and once after completion. Providers are asked
these questions:
￿ How confident are you in the home monitoring of
your sickest patient?
￿ Do you feel that our practice has a good system of
maintaining the functional status and health of our
patients?
￿ How confident are you that a home-based system
that allows monitoring of vital signs and symptoms
will help in patient care?
￿ Would you be willing to recommend a home-based
telemonitoring system that allows videoconferencing?
Outcomes measurement
The primary outcomes are hospitalizations, ED visits,
and the composite outcome of hospitalizations and ED
visits. Olmsted County has two primary medical centers,
and all listed outcomes can be collected through the
Rochester Epidemiology Project. Patient self-reports will
also be used to capture care provided outside of
Olmsted County, and these events will be verified by the
study team. In addition, Medicare claims data will be
reviewed for hospitalizations and associated costs. In
practical terms, almost all patients who visit PCIM pre-
ferentially use Mayo facilities for ED and hospital care.
These measures will be obtained from the medical
record.
An economic analysis will be performed comparing
usual care and home telemonitoring, including total
non-elective care costs based on reimbursement from
Medicare, Medicaid, and private insurance. Cost analysis
will also use standard Centers for Medicare and Medi-
caid Services (CMS) costing information and reimburse-
ment information. This will include inpatient,
outpatient, and skilled nursing facility stays, and home
healthcare adjusted for CMS Hierarchical Condition
C o d e sa n dr e g i o n a lv a r i a t i o na sw e l la sa l ld i r e c ta n d
indirect costs of the telemonitoring.
Sample size
Using an alpha value of 0.05 and a power of 80%, the
power calculations were derived from an estimated 76%
event rate of hospitalizations and ED visits in 2 years in
the high-risk group. Using a time-to-event approach with
a 25% reduction when the sample size in each group is
352, with a total number of events required, E, of 463, a
0.050 level two-sided log-rank test for equality of survival
curves will have 80% power to detect the difference
between a Group 1 proportion π1 at time t of 0.380 and a
Group 2 proportion π2 at time t of 0.285 (a constant
hazard ratio of 0.771); this assumes no dropouts before
time t. Using 100 patients in each group with a yearly
hospitalization/ED rate of 38.2%, we will be able to detect
a 36.1% decrease in combined outcomes. Table 3 below
reflects the changes with different size groups.
Data analysis
All analysis will be performed according to group using
an intention-to-treat method. The primary outcomes of
combined hospitalizations and ED visits will be analyzed
using a time-to-event, Cox proportional analysis. Adjust-
ment will be made to the time-to-event analysis only if
there are clear differences between the randomized
groups. As a secondary method of analysis, the total
number of ED visits and hospitalizations will be com-
pared using a t-test. Initial descriptive data will be
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metric data. Non-parametric data will be presented with
modes and 25 to 75 interquartile ranges.
Secondary data analysis will involve comparisons
between the intervention group and the usual care
group, with these dependent variables: SF-12 scores and
sub scores, PHQ-9 scores, Kokmen Short Test of Men-
tal Status scores, Katz Index of Independence in Activ-
ities of Daily Living scores, and Likert Scale scores for
attitudes toward health and compliance (Table 4). All
categorical variables will be analyzed using a t-test
where appropriate, and proportional variables will be
analyzed using chi square analysis for secondary out-
comes. All tests for significance will use an alpha p-
value of 0.05. Adjustments for multiple comparisons will
be used for secondary analysis. All tests will assume a
two-sided p-value.
Discussion
Appropriate, efficient, and cost-effective care for older
adults remains an important objective for both patients
and providers in healthcare. It is predicted that the
number of adults older than age 65 will double in the
next 20 years [4]. These older adults are at higher risk
for accidents and geriatric conditions such as urinary
incontinence [12]. The large post-World War II cohort
will require changes in how healthcare is delivered as a
result of both increased numbers and required intensity
of care. The utilization of efficient systems may help to
mitigate some of the potential shortages of staff and
resources. Telemonitoring has emerged as one possible
solution to help efficiently care for older adults [13].
The potential advantages of telemonitoring are many;
however, one must look at the potential costs involved
with such a system.
The earliest methods of home monitoring were lim-
ited to periodic nurse telephone support, with or with-
out other limited forms of data transmission such as
cardiac rhythm monitoring. Telephone-based care has
been used successfully, particularly in congestive heart
failure (CHF), with a demonstrated 50% reduction in
hospital readmissions through the use of nurse tele-
phone support with remote cardiac rhythm monitoring
[14]. However, the clinical desire to provide more fre-
quent and detailed monitoringo fe x p a n d e dp h y s i o l o g i c
parameters and to have a remote “face-to-face” interac-
tion with the patient has lead to the development of
more sophisticated telemonitoring equipment. This
equipment provides direct visual and audio communica-
tion through video monitoring and expands the ability
to frequently assess patient status via capabilities (e.g.,
oximetry, spirometry, direct vital sign measurement,
remote auscultation, blood glucose measurement). It can
be monitored in a synchronous fashion to facilitate early
intervention. One might easily imagine this type of tech-
nology to have the greatest impact potential for older
adults who may be challenged to collect their own phy-
siologic data and communicate well solely over the
telephone.
Telemonitoring using updated equipment has been
quite successful for chronic disease management. The
initial use of telemonitoring targeted patients who live
long distances from medical or specialty care [15].
Increasingly, telemonitoring has sought to help indivi-
duals with chronic illnesses (e.g., CHF, chronic obstruc-
tive pulmonary disease [COPD], diabetes) that require
Table 3 Sample sizes for hospitalizations and emergency department visits
Sample size % hospitalized in intervention % with ED/hospitalization in intervention
100 27.1 (42.5% drop) 38.2 (36.1% drop)
150 30.7 (34.8% drop) 42.1 (28.6% drop)
200 32.9 (30.1% drop) 44.4 (24.6% drop)
250 34.4 (27.0% drop) 46.0 (21.9% drop)
300 35.5 (24.6% drop) 47.2 (19.9% drop)
350 36.4 (22.7% drop) 48.1 (18.3% drop)
Table 4 Statistical analysis for secondary outcomes
Instrument/measure Variable type Test Significance
Kokmen Short Test of Mental Status Continuous score t-test Alpha 0.05
SF-12 Proportional for items or continuous Fisher’s exact test or t-test Alpha 0.05
Likert scale scores for attitudes and behavior Continuous t-test Alpha 0.05
PHQ-9 Continuous t-test Alpha 0.05
Katz Index of Independence in Activities of Daily Living Continuous t-test Alpha 0.05
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is to identify and treat symptoms, functional decline,
and other key changes in medical status before the
patient requires acute care in an ED or hospital or long-
term care in a skilled nursing facility. The results of
many demonstration projects and pilot studies evaluat-
ing the effectiveness of telemonitoring have been favor-
able; however, the projects have been often limited to a
single disease model. Diabetes has been widely studied
in randomized controlled trials [16-18]. In the diabetic
population, using a meta-analysis, on aggregate, the
patients favorably endorsed home telemonitoring and
had lower hospital readmissions and improved hemoglo-
bin A1c levels [3]. In the CHF studies, all-cause mortal-
ity dropped by 40% and hospitalizations by 20% [3].
Some of the CHF studies did not demonstrate a
decrease in ED visits compared with usual care [19].
Patients with mixed chronic diseases remain the most
understudied group, yet many older adults have more
than one chronic illness [20]. In a randomized con-
trolled trial of 53 patients with CHF, COPD, or a
chronic wound, fewer patients were re-hospitalized in
the telemonitoring group, which used a device capable
of videoconferencing and physiologic monitoring of vital
signs, spirometry, and pulse oximetry [21]. In a similar
study of 104 patients with CHF, COPD, and/or diabetes,
Noel [22] demonstrated reduced bed days and ED visits
when patients at home used a device capable of measur-
ing vital signs, blood glucose levels, three-lead electro-
cardiography, pulse oximetry, auscultation of heart and
lungs, and pain assessment. However, cost analysis was
limited to a previous 6-month comparison, making
interpretation difficult. Videoconferencing was not avail-
able for this study. In a recent review for the Canadian
government, this study was the only publication on
elderly patients with mixed chronic disease given the
quality score of B (good), with the remainder deemed to
have significant shortcomings [3].
The primary concern for many healthcare organiza-
tions undertaking telemonitoring is the cost justification
for the clinical and capital investment. While the cost
benefits of reduced utilization and functional decline are
self-evident, the costs of telemonitoring have not been
well-analyzed to date. In an example analysis of a single
published work, the estimated annual cost for patients
in the telemonitoring group was $14,678, compared
with $10,161 for the usual care [3]. However, remaining
methodologic issues suggested lack of comprehensive
cost accounting and validated staffing protocols. More-
over, the quality of the economic evaluations to date
have been deemed poor, and the report called for more
studies of higher methodologic quality to include more
diverse patient populations with CHF, diabetes, and
COPD to increase external validity [3].
The proposed study will address the need for more
rigorous study of the role of home telemonitoring in
elderly patients with mixed chronic disease. We will use
a unique, validated risk assessment index to systemati-
cally identify patients at high risk for hospitalization, ED
visits, nursing home placement, and death. The study
size will exceed the largest study to date for the mixed
c h r o n i cd i s e a s ep o p u l a t i o n .W ew i l lp r o v i d eam o r e
robust analysis of key clinical outcomes and economic
impacts not yet fully characterized and use these results
in future studies comparing telemonitoring to care-tran-
sition programs. We will also use the results to define
populations most suitable for these and similar interven-
tions targeted to sustaining late-life independent living.
This study may also provide a background for other
monitoring devices.
The strengths of this study include the randomized
trial approach, which will allow the groups to be ran-
domly assigned and minimize the differences between
the groups. The usual care group includes the standar-
dized followup for patients, which is the standard of
care for high-risk elderly patients in Rochester. The tele-
monitoring intervention group is based on cutting-edge
technology for monitoring at home. The clinical group
includes experienced midlevel nurse providers and RNs
who oversee the management of home medical care.
Patients also have a connection with their primary phy-
sician, who is informed of major clinical changes. Lastly,
the group is maintained in a closed medical system of
two major hospital groups in Olmsted County, with
most care provided by the PCIM.
The major limitation is the lack of blinding inherent
with two disparate groups of patients. This could lead to
the Hawthorne Effect and lead to bias. It will not be
practical to blind the providers or the patients receiving
home equipment and constant monitoring at home. The
limitations imposed will be mitigated despite the lack of
blinding. Specifically, hospitalizations and ED visits as
the primary outcome should occur regardless of arm or
treatment and are not subjective measures. There is the
potential for recall bias on self-reported outcomes; how-
ever, the primary outcomes should be captured by the
medical record in nearly all cases.
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